{
    "Trade/Device Name(s)": [
        "HemosIL HIT-Ab(PF4-H)",
        "HemosIL HIT-Ab(PF4-H) Controls"
    ],
    "Submitter Information": "Instrumentation Laboratory (IL) Co.",
    "510(k) Number": "K153137",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003767"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCO",
        "GGN"
    ],
    "Summary Letter Date": "June 6, 2016",
    "Summary Letter Received Date": "June 8, 2016",
    "Submission Date": "June 28, 2016",
    "Regulation Number(s)": [
        "21 CFR 864.7695",
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Platelet factor 4 radioimmunoassay",
        "Plasma, Coagulation Control"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation",
        "immunology"
    ],
    "Analyte(s)": [
        "Anti-platelet factor 4/heparin (PF4/H) antibodies"
    ],
    "Specimen Type(s)": [
        "Citrated human plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACL TOP Family of instruments",
        "ACL TOP 700",
        "ACL TOP 500 CTS",
        "ACL TOP 300 CTS"
    ],
    "Method(s)/Technology(ies)": [
        "Latex-enhanced immuno-turbidimetric assay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Turbidimetry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Calibrator",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL HIT-Ab(PF4-H) latex-enhanced immuno-turbidimetric assay and controls for detection of anti-PF4/heparin antibodies in citrated plasma using ACL TOP instruments.",
    "Indications for Use Summary": "Qualitative, fully automated immunoassay for detection of anti-platelet factor 4/heparin antibodies in citrated plasma to aid in determining risk for heparin induced thrombocytopenia (HIT) in adults, for use with ACL TOP instruments; controls for assay quality control.",
    "fda_folder": "Hematology"
}